PeopleBio, Inc. (KOSDAQ: 304840)

Market Cap	78.13B
Revenue (ttm)	4.46B
Net Income (ttm)	-13.21B
Shares Out	21.03M
EPS (ttm)	-663.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	866,462
Open	3,800.00
Previous Close	3,835.00
Day's Range	3,520.00 - 4,100.00
52-Week Range	2,590.00 - 6,090.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2002
• Employees: 65
• Stock Exchange: KOSDAQ
• Ticker Symbol: 304840

Financial Performance

In 2023, PeopleBio's revenue was 4.45 billion, an increase of 0.18% compared to the previous year's 4.44 billion. Losses were -16.03 billion, 12.1% more than in 2022.